Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Single Centre, Single-blind, Randomized, Two-part, 6-way Cross-over Study to Investigate the Individual Bioequivalence of Gabasandoz Relative to Neurontin in Healthy Volunteers.

Trial Profile

A Single Centre, Single-blind, Randomized, Two-part, 6-way Cross-over Study to Investigate the Individual Bioequivalence of Gabasandoz Relative to Neurontin in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jan 2019

At a glance

  • Drugs Gabapentin (Primary)
  • Indications Amyotrophic lateral sclerosis; Anxiety disorders; Bipolar disorders; Epilepsy; Hot flashes; Migraine; Neuralgia; Neuropathic pain; Postherpetic neuralgia; Restless legs syndrome; Spinal muscular atrophy
  • Focus Pharmacokinetics
  • Most Recent Events

    • 13 Jan 2019 Results published in the Clinical Pharmacology and Therapeutics
    • 06 Apr 2013 New trial record
    • 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top